The cumulative risk of BC by 80 years of age in healthy female carriers of BRCA1 mutation is about 80% (Kuchenbaecker et al., 2017; King et al., 2003) while one in eight women will develop BC over the lifespan in the general population. This evidence concerns the gene BRCA1 and breast cancer.